PRKAA1 and cervical cancer: Herein we applied the AMPK agonist metformin and demonstrated that AMPK activation inhibits cervical cancer growth both in vitro and in vivo, accompanied by significant changes in the levels of acetylation modifications on both histones and non-histones.